https://www.selleckchem.com/pr....oducts/polyethylenim
02%/year no PAD vs 4.08%/year PAD, P=.02), myocardial infarction (0.99%/year no PAD vs 2.43%/year PAD, P=.02) and MACE (3.18%/year no PAD vs 6.99%/year PAD, P.01). There was no statistically significant association with these events after multivariable adjustment. In a large cohort of anticoagulated patients with AF, the presence of PAD represents a higher risk subgroup and is associated with worse crude outcomes. The exact contribution of the PAD independently of other cardiovascular diseases or risk factors requires furth
Like
Comment
Share
